查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球生物材料傷口敷料市場-2022-2029
市場調查報告書
商品編碼
1140682

全球生物材料傷口敷料市場-2022-2029

Global Biomaterial Wound Dressing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

在預測期內，不斷上升的傷口感染推動市場增長

由於衛生條件差、糖尿病、肥胖等導致傷口感染的發病率不斷增加，這促進了傷口敷料市場的增長。傷口敷料用於通過將其應用於感染區域來減少傷口感染。感染是不方便的、痛苦的，並導致傷口癒合失敗或延遲。在某些情況下，傷口感染非常嚴重，會導致壞死性蜂窩織炎和筋膜炎，擴散到局部骨骼、肌腱和關節組織，並導致全身性疾病和轉移到脊柱等遠處部位。

此外，由於全球手術數量的增加，全球生物材料傷口敷料市場正在經歷顯著增長。此外，隨著整形手術的增加，它被應用於整形手術的傷口癒合，帶動了傷口敷料市場。在美國，外科和非外科整容手術正在興起。例如，到 2021 年，美國將進行超過 550 萬例涉及毒素和填充物的手術，將有 491,000 人接受這些手術。

地理滲透。

北美是預測期內的主要地區。

在預測期內，北美市場佔全球生物材料傷口敷料市場的最大市場份額。促進北美市場增長的因素包括壓力性潰瘍發病率的增加和燒傷人數的增加。此外，估計外科手術數量的增加和主要參與者的存在也有助於市場的增長。

此外，亞太地區正在經歷全球最高的人口老齡化率，加上整個亞太經濟體的潰瘍患病率、燒傷事件增加和糖尿病患病率上升。預計該地區將以復合年增長率增長.到2020年，預計老年人口將達到2.55億，至少佔中國總人口的17.8%。隨著年齡的增長，預計亞太地區人口中的潰瘍病例會增加，這被認為會增加傷口的可能性。

競爭格局。

生物材料傷口敷料市場由少數公司主導。市場增長參與者包括 3M 公司、ConvaTec Group PLC、DermaRite Industries LLC、B. Braun Melsungen AG、Hollister Incorporated、Integra LifeSciences Holdings Corporation、強生公司和美敦力公司。預計主要參與者將執行多項增長戰略，例如產品發布、收購和合作，這將推動全球生物材料傷口敷料市場。 2022 年 8 月，3M Health Care 的醫療解決方案業務宣布升級以加速某些傷口護理技術的交付。這種名為 3M VAC Ulta 治療裝置的新型生物材料傷口裝置是免費向客戶推出的。用於開放性軟組織傷口的患者，以幫助促進清潔和肉芽組織的形成。當需要立即清潔傷口時，該套件有助於軟化、溶解、破壞和去除厚的或不易腐爛的組織。 3M 公司提供範圍廣泛的傷口護理解決方案。 3M 開發了一種新的敷料套件，以簡化各種敷料的應用。 2022 年 1 月，ConvaTec 集團簽訂了收購 Triad LifeSciences, Inc. 的最終協議，該公司是一家創新生物衍生產品的開發商，用於滿足外科傷口、慢性傷口和燒傷方面未滿足的臨床需求。此次收購加強了 Convatec 在美國的先進傷口護理地位，提供了一個創新的技術平台，可改善先進的傷口管理和患者治療效果。

COVID-19 的影響將對全球生物材料傷口敷料市場產生負面影響。

預計 COVID-19 大流行的爆發將破壞 2020 年生物材料傷口敷料市場的增長。事故和醫院就診次數的下降是對 2020 年生物材料傷口敷料市場增長產生負面影響的主要因素。但是，預計市場將受到更嚴格的鎖定要求的負面影響，以避免 COVID-19 污染和由於遠程辦公設施而減少的交通事故。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按產品劃分的市場細分
  • 按應用劃分的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 增加外科手術
      • 運動傷害增加
    • 限制
      • 對高級傷口護理產品的認知度低
    • 商機
    • 影響分析

第5章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品分類

  • 水膠體
  • 海藻酸鹽敷料
  • 皮膚替代品
  • 其他

第 8 章按應用程序

  • 傷口
  • 燒傷
  • 潰瘍
  • 其他

第 9 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 10 章競爭格局

  • 競爭場景
  • 市場定位/市場份額分析
  • 併購分析

第 11 章公司簡介

  • 3M 公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • B. Braun Melsungen AG
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Molnlycke Health Care AB
  • Smith & Nephew PLC
  • Hunan Sanzhong Medical Dressing Co., Ltd.
  • Changzhou Hualian Health Dressing Co., Ltd.
  • Yangzhou Super Union Medical Material Co., Ltd.
  • Other Companies（*LIST NOT EXHAUSTIVE）

第12章 DataM

簡介目錄
Product Code: DMHCIT2975

Market Overview

Biomaterial Wound Dressing Market is expected to grow at a CAGR of 10.8% during the forecasting period (2022-2029).

Biomaterial wound healing can be categorized in several ways, depending on its chemical nature, source, type of dressing, or application. Synthetic biomaterials consist of organic and inorganic polymers. In contrast, natural biomaterials include biological products derived from plant, fungal, animal, or bacterial sources that can, in turn, be divided into proteins, polysaccharides, or macromolecules combining proteins and polysaccharides. The rising incidence of chronic wounds such as ulcers is significantly creating the demand for wound dressing products, augmenting the market growth. The rising incidence of wound infection and an increasing number of surgeries also demand advanced and traditional wound care products.

Market Dynamics: Rising incidence of wound infection drives the market's growth during the forecast period.

The increasing incidence of wound infection due to poor hygiene, diabetes, obesity, and others contributes to the growth of the wound dressing market. The wound dressing is used to reduce the wound infection by placing it on the infection area. Infections are inconvenient and painful and lead to failure or delay in wound healing. In some cases, wound infection is very severe, causing necrotizing cellulitis or fasciitis; it spreads into the local bone, tendon, or joint tissues; systemic disease or metastatic spread to the spine or other distant sites.

Moreover, the global biomaterial wound dressing market is experiencing significant growth due to the increasing number of surgeries worldwide. Moreover, the increasing number of plastic surgeries is driving the wound dressing market due to its application for wound healing in plastic surgeries. The increasing number of surgical and nonsurgical cosmetic procedures in the United States is significant. For instance, in 2021, more than 5.5 million procedures involved toxins and fillers, and 491 thousand performed surgeries in the United States.

Market Segmentation: Hydrocolloid dressing segment accounted for the highest share in global biomaterial wound dressing market.

Hydrocolloid dressings are bandages made of gel-forming agents such as gelatin and pectin that form a moist environment with the body that promotes healing. The hydrocolloid dressings absorb fluid from the wound and are generally recommended for minor burns, leg ulcers, pressure sores, and traumatic injuries. Such dressings can be kept for several days, as it slowly aids the healing process and maintains the wound environment. Hydrocolloid dressings are available in the market in various shapes and sizes. The widely used hydrocolloid dressing brands available in the market include Duoderm GCF, Comfeel, Actiderm, and Hydrosol.

The biomaterial wound dressing market is classified into wounds, burns, ulcers, and others by the application. The wound segment held a significant share in the market growth. Wounds dominated the biomaterial wound dressing market in the forecast period. Surgical wound contributes majorly to segmental growth across the globe. A surgical wound is a cut that is generally made by using a scalpel during the surgical procedure. There are primarily two types of surgical wounds following surgery, including incisional wounds and excisional wounds. Incisional wounds are made by cutting through fat, skin, and muscle, enabling body parts to be removed or repaired. The biomaterial wound dressings play an important role in controlling any postoperative bleeding, offering protection to newly developed tissue, and easing pain.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market dominated the largest market share in the global biomaterial wound dressing market in the forecast period. Factors augmenting the North American market's growth include the increasing incidence of pressure ulcers and a rising number of burning injury cases. Further, the rising number of surgical procedures and the presence of major players are also estimated to contribute to the market's growth.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally due to the growing aging population coupled with the increasing prevalence of ulcers, increasing number of burn cases, and the rising prevalence of diabetes across the Asia Pacific economies. By 2020, there were 255 million elders, representing at least 17.8% of the entire Chinese population. With the age dynamics, ulcer cases among the population of Asia-Pacific are expected to grow, which is expected to increase the chances of wounds.

Competitive Landscape:

The biomaterial wound dressing market is dominated by a few companies. Some of the key players in the market's growth include 3M Company, ConvaTec Group PLC, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global biomaterial wound dressing market. In August 2022, The 3M Health Care's medical solutions business announced upgrades to advance the delivery of certain wound care technologies. This new biomaterial wound unit, named 3M VAC Ulta therapy unit, was introduced at no increased cost to the customer. It is used for patients with open soft tissue wounds to help cleanse and stimulate the formation of granulation tissue. This kit helps to soften, solubilize, disrupt, and remove thick and non-viable tissue when immediate wound cleansing is needed. 3M company offers a wide range of wound care solutions. 3M developed the new dressing kit to simplify various dressing applications. In January 2022, ConvaTec Group entered into a definitive agreement to acquire Triad Life Sciences Inc, which develops biologically-derived innovative products to address unmet clinical needs in surgical wounds, chronic wounds and burns. This acquisition strengthens Convatec's Advanced Wound Care position in the United States and provides an innovative technology platform that enhances advanced wound management and patient outcomes.

COVID-19 Impact: Negative impact on the global biomaterial wound dressing market.

The outbreak of the COVID-19 pandemic is expected to derail the biomaterial wound dressing market's growth in 2020. The decline in accidents and the number of hospital visits is the major factor that has negatively impacted the biomaterial wound dressing market growth in 2020. However, the market is expected to have a negative impact due to the decrease in road accidents due to strict lockdown conditions and work-from-home facilities to avoid contamination of COVID-19.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising incidence of surgical procedures
      • 4.1.1.2. An increasing number of sports-related injuries
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness of advanced wound care products
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Hydrocolloids*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Alginate Dressing
    • 7.3.3. Skin Substitutes
    • 7.3.4. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Wound*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Burns
    • 8.3.3. Ulcers
    • 8.3.4. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. 3M Company*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. ConvaTec Group PLC
  • 11.3. DermaRite Industries LLC
  • 11.4. B. Braun Melsungen AG
  • 11.5. Hollister Incorporated
  • 11.6. Integra LifeSciences Holdings Corporation
  • 11.7. Johnson & Johnson
  • 11.8. Medtronic PLC
  • 11.9. Molnlycke Health Care AB
  • 11.10. Smith & Nephew PLC
  • 11.11. Hunan Sanzhong Medical Dressing Co., Ltd.
  • 11.12. Changzhou Hualian Health Dressing Co., Ltd.
  • 11.13. Yangzhou Super Union Medical Material Co., Ltd.
  • 11.14. Other Companies (*LIST NOT EXHAUSTIVE)

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us